Annual EBITDA:
-$373.62M-$1.55B(-131.73%)Summary
- As of today, BNTX annual EBITDA is -$373.62 million, with the most recent change of -$1.55 billion (-131.73%) on December 31, 2024.
- During the last 3 years, BNTX annual EBITDA has fallen by -$21.31 billion (-101.78%).
- BNTX annual EBITDA is now -101.78% below its all-time high of $20.93 billion, reached on December 31, 2021.
Performance
BNTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$888.56M+$1.45B(+258.03%)Summary
- As of today, BNTX quarterly EBITDA is $888.56 million, with the most recent change of +$1.45 billion (+258.03%) on September 30, 2025.
- Over the past year, BNTX quarterly EBITDA has increased by +$438.71 million (+97.52%).
- BNTX quarterly EBITDA is now -83.46% below its all-time high of $5.37 billion, reached on September 30, 2021.
Performance
BNTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$187.96M+$438.71M(+174.96%)Summary
- As of today, BNTX TTM EBITDA is $187.96 million, with the most recent change of +$438.71 million (+174.96%) on September 30, 2025.
- Over the past year, BNTX TTM EBITDA has increased by +$225.75 million (+597.37%).
- BNTX TTM EBITDA is now -99.10% below its all-time high of $20.91 billion, reached on March 31, 2022.
Performance
BNTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -131.7% | +97.5% | +597.4% |
| 3Y3 Years | -101.8% | -60.7% | -98.7% |
| 5Y5 Years | -123.1% | +508.9% | +146.2% |
BNTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -101.8% | at low | -74.9% | +227.1% | -98.7% | +148.5% |
| 5Y | 5-Year | -101.8% | at low | -83.5% | +227.1% | -99.1% | +146.2% |
| All-Time | All-Time | -101.8% | at low | -83.5% | +227.1% | -99.1% | +146.2% |
BNTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $888.56M(+258.0%) | $187.96M(+175.0%) |
| Jun 2025 | - | -$562.29M(-5.9%) | -$250.75M(+35.3%) |
| Mar 2025 | - | -$530.86M(-235.2%) | -$387.78M(-4.6%) |
| Dec 2024 | -$373.62M(-131.7%) | $392.54M(-12.7%) | -$370.62M(-880.7%) |
| Sep 2024 | - | $449.85M(+164.3%) | -$37.79M(+89.5%) |
| Jun 2024 | - | -$699.32M(-36.1%) | -$359.28M(-100.0%) |
| Mar 2024 | - | -$513.70M(-170.8%) | -$179.64M(-115.8%) |
| Dec 2023 | $1.18B(-92.7%) | $725.37M(+465.1%) | $1.14B(-71.3%) |
| Sep 2023 | - | $128.36M(+124.7%) | $3.96B(-35.0%) |
| Jun 2023 | - | -$519.68M(-164.9%) | $6.09B(-29.6%) |
| Mar 2023 | - | $801.27M(-77.4%) | $8.65B(-34.2%) |
| Dec 2022 | $16.10B(-23.1%) | $3.55B(+56.8%) | $13.14B(-11.2%) |
| Sep 2022 | - | $2.26B(+10.8%) | $14.80B(-17.4%) |
| Jun 2022 | - | $2.04B(-61.4%) | $17.91B(-14.3%) |
| Mar 2022 | - | $5.29B(+1.6%) | $20.91B(+19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $20.93B(+8159.2%) | $5.21B(-3.1%) | $17.50B(+42.1%) |
| Sep 2021 | - | $5.37B(+6.6%) | $12.31B(+83.1%) |
| Jun 2021 | - | $5.04B(+167.4%) | $6.73B(+318.2%) |
| Mar 2021 | - | $1.88B(+9082.4%) | $1.61B(+583.8%) |
| Dec 2020 | -$259.75M(-55.1%) | $20.52M(+109.4%) | -$332.42M(+18.2%) |
| Sep 2020 | - | -$217.30M(-173.6%) | -$406.63M(-91.1%) |
| Jun 2020 | - | -$79.44M(-41.3%) | -$212.78M(-20.1%) |
| Mar 2020 | - | -$56.21M(-4.7%) | -$177.19M(-11.8%) |
| Dec 2019 | -$167.49M(-288.5%) | -$53.69M(-129.0%) | -$158.55M(-64.0%) |
| Sep 2019 | - | -$23.45M(+46.5%) | -$96.67M(-4.9%) |
| Jun 2019 | - | -$43.85M(-16.7%) | -$92.18M(-90.7%) |
| Mar 2019 | - | -$37.57M(-558.5%) | -$48.33M(-349.0%) |
| Dec 2018 | -$43.12M(+27.7%) | $8.19M(+143.2%) | -$10.76M(+43.2%) |
| Sep 2018 | - | -$18.96M | -$18.96M |
| Dec 2017 | -$59.61M | - | - |
FAQ
- What is BioNTech SE annual EBITDA?
- What is the all-time high annual EBITDA for BioNTech SE?
- What is BioNTech SE annual EBITDA year-on-year change?
- What is BioNTech SE quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BioNTech SE?
- What is BioNTech SE quarterly EBITDA year-on-year change?
- What is BioNTech SE TTM EBITDA?
- What is the all-time high TTM EBITDA for BioNTech SE?
- What is BioNTech SE TTM EBITDA year-on-year change?
What is BioNTech SE annual EBITDA?
The current annual EBITDA of BNTX is -$373.62M
What is the all-time high annual EBITDA for BioNTech SE?
BioNTech SE all-time high annual EBITDA is $20.93B
What is BioNTech SE annual EBITDA year-on-year change?
Over the past year, BNTX annual EBITDA has changed by -$1.55B (-131.73%)
What is BioNTech SE quarterly EBITDA?
The current quarterly EBITDA of BNTX is $888.56M
What is the all-time high quarterly EBITDA for BioNTech SE?
BioNTech SE all-time high quarterly EBITDA is $5.37B
What is BioNTech SE quarterly EBITDA year-on-year change?
Over the past year, BNTX quarterly EBITDA has changed by +$438.71M (+97.52%)
What is BioNTech SE TTM EBITDA?
The current TTM EBITDA of BNTX is $187.96M
What is the all-time high TTM EBITDA for BioNTech SE?
BioNTech SE all-time high TTM EBITDA is $20.91B
What is BioNTech SE TTM EBITDA year-on-year change?
Over the past year, BNTX TTM EBITDA has changed by +$225.75M (+597.37%)